Narrative review / 2016
An expert panel review concluded that evidence does not support glyphosate as a probable human carcinogen.
Four independent Expert Panels reviewed the carcinogenic potential of glyphosate and critiqued the 2015 IARC assessment. Neoplasms in animal bioassays were determined not to be associated with glyphosate due to lack of statistical strength, inconsistency, and lack of dose-response relationships. Genetic toxicology data indicated glyphosate, GBFs, and AMPA do not pose a genotoxic hazard, while epidemiological data did not support a causal link with non-Hodgkin's lymphoma and were too sparse for multiple myeloma. The panels concluded that glyphosate is unlikely to pose a carcinogenic risk to humans.
- Study type
- Expert panel evidence review
- Who was studied
- Epidemiological, animal, and genetic toxicology datasets
- What was measured
- Carcinogenic potential, genotoxicity, and non-Hodgkin's lymphoma risk
THE PAPER
A review of the carcinogenic potential of glyphosate by four independent expert panels and comparison to the IARC assessment.
Williams GM, Aardema M, Acquavella J, Berry SC, Brusick D, Burns MM, de Camargo JLV, Garabrant D, Greim HA, Kier LD, Kirkland DJ, Marsh G, Solomon KR, Sorahan T, Roberts A, Weed DL. Crit Rev Toxicol, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.